Filtered By:
Drug: Dexamethasone

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 6433 results found since Jan 2013.

Intravitreal dexamethasone to manage post endothelial keratoplasty cystoid macular oedema refractory to topical therapy
Eur J Ophthalmol. 2023 Aug 22:11206721231189120. doi: 10.1177/11206721231189120. Online ahead of print.NO ABSTRACTPMID:37605631 | DOI:10.1177/11206721231189120
Source: European Journal of Ophthalmology - August 22, 2023 Category: Opthalmology Authors: Nuno Moura-Coelho Renato Papa-Vettorazzi Jos é L Güell Source Type: research

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
CONCLUSION: Atezolizumab plus carboplatin and pemetrexed demonstrates activity in patients with advanced nonsquamous NSCLC with untreated brain metastases with an acceptable safety profile.PMID:37603816 | DOI:10.1200/JCO.22.02561
Source: Clinical Lung Cancer - August 21, 2023 Category: Cancer & Oncology Authors: Ernest Nadal Delvys Rodr íguez-Abreu Marta Sim ó Bartomeu Massut í Oscar Juan Gerardo Huidobro Rafael L ópez Javier De Castro Anna Estival Joaqu ín Mosquera Ivana Sullivan Enriqueta Felip Ana Blasco Maria Guirado Eva Pereira Noelia Vilari ño Valent Source Type: research

Development of a Rabbit Human Glioblastoma Model for Testing of Endovascular Selective Intra-Arterial Infusion (ESIA) of Novel Stem Cell-Based Therapeutics
CONCLUSIONS: The intracranial immunosuppressed rabbit human GBM model allows testing of ESIA infusion of novel therapeutics (e.g., MSC-D24) in a clinically relevant fashion.PMID:37603323 | DOI:10.1093/neuonc/noad152
Source: Ann Oncol - August 21, 2023 Category: Cancer & Oncology Authors: Peter Kan Visish M Srinivasan Joy Gumin Roberto Garcia Stephen R Chen Jeremiah N Johnson Dalis E Collins Melissa M Chen Daniel Ledbetter Jason Huse Zean Aaron Evan Luna Ariadna Robledo Viren Vasandani Abhijit Rao Sanjay K Singh Elizabeth J Shpall Juan Fue Source Type: research

Cochlear implant surgery facilitates intracochlear distribution of perioperative systemic steroids
CONCLUSIONS AND SIGNIFICANCE: This study demonstrates that the inner ear distribution of systemically administered steroids is enhanced following surgery for cochlear implantation and provides rationale for systemic perioperative steroids in hearing preservation surgery.PMID:37603289 | DOI:10.1080/00016489.2023.2241877
Source: Acta Oto-Laryngologica - August 21, 2023 Category: ENT & OMF Authors: Nathan J Creber Hayden T Eastwood Amy J Hampson Stephen J O'Leary Source Type: research

Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes
CONCLUSION: In conclusion, selinexor-based therapy provides an additional treatment option in the real word setting and with appropriate dosing and toxicity management a subset of patients may have significant benefit.PMID:37599164 | DOI:10.1016/j.clml.2023.07.013
Source: Clinical Lymphoma and Myeloma - August 20, 2023 Category: Cancer & Oncology Authors: Efstathios Kastritis Maria Gavriatopoulou Eirini Solia Foteini Theodorakakou Vasiliki Spiliopoulou Panagiotis Malandrakis Ioannis Ntanasis-Stathopoulos Magdalini Migkou Nikoleta Kokkali Evangelos Eleutherakis-Papaiakovou Rodanthi Syrigou Despina Fotiou Ev Source Type: research

Testing anabolic activity, potency and mechanisms of action of the phyto-derived beta 2 agonist higenamine
Toxicol Lett. 2023 Aug 18:S0378-4274(23)00243-6. doi: 10.1016/j.toxlet.2023.08.007. Online ahead of print.ABSTRACTHigenamine (Hige), a plant derived alkaloid is classified as β2 agonist by the World Anti-Doping Agency (WADA). However, pharmacologic mechanisms of its performance-enhancing activity have not been investigated so far. Therefore, we investigate the anabolic activity and associated molecular mechanisms of Hige in C2C12 myotubes. In differentiated C2C12 cells dose-dependent effects of Hige on myotube size were analyzed. The mRNA expression of genes involved in hypertrophy was measured. For mechanistic studies, Î...
Source: Toxicology Letters - August 20, 2023 Category: Toxicology Authors: L Jiang M Piribauer T Kostov S Steidel D A Bizjak J M Steinacker M Parr P Diel Source Type: research

Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes
CONCLUSION: In conclusion, selinexor-based therapy provides an additional treatment option in the real word setting and with appropriate dosing and toxicity management a subset of patients may have significant benefit.PMID:37599164 | DOI:10.1016/j.clml.2023.07.013
Source: Clinical Lymphoma and Myeloma - August 20, 2023 Category: Cancer & Oncology Authors: Efstathios Kastritis Maria Gavriatopoulou Eirini Solia Foteini Theodorakakou Vasiliki Spiliopoulou Panagiotis Malandrakis Ioannis Ntanasis-Stathopoulos Magdalini Migkou Nikoleta Kokkali Evangelos Eleutherakis-Papaiakovou Rodanthi Syrigou Despina Fotiou Ev Source Type: research

Testing anabolic activity, potency and mechanisms of action of the phyto-derived beta 2 agonist higenamine
Toxicol Lett. 2023 Aug 18:S0378-4274(23)00243-6. doi: 10.1016/j.toxlet.2023.08.007. Online ahead of print.ABSTRACTHigenamine (Hige), a plant derived alkaloid is classified as β2 agonist by the World Anti-Doping Agency (WADA). However, pharmacologic mechanisms of its performance-enhancing activity have not been investigated so far. Therefore, we investigate the anabolic activity and associated molecular mechanisms of Hige in C2C12 myotubes. In differentiated C2C12 cells dose-dependent effects of Hige on myotube size were analyzed. The mRNA expression of genes involved in hypertrophy was measured. For mechanistic studies, Î...
Source: Toxicology Letters - August 20, 2023 Category: Toxicology Authors: L Jiang M Piribauer T Kostov S Steidel D A Bizjak J M Steinacker M Parr P Diel Source Type: research

Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes
CONCLUSION: In conclusion, selinexor-based therapy provides an additional treatment option in the real word setting and with appropriate dosing and toxicity management a subset of patients may have significant benefit.PMID:37599164 | DOI:10.1016/j.clml.2023.07.013
Source: Clinical Lymphoma and Myeloma - August 20, 2023 Category: Cancer & Oncology Authors: Efstathios Kastritis Maria Gavriatopoulou Eirini Solia Foteini Theodorakakou Vasiliki Spiliopoulou Panagiotis Malandrakis Ioannis Ntanasis-Stathopoulos Magdalini Migkou Nikoleta Kokkali Evangelos Eleutherakis-Papaiakovou Rodanthi Syrigou Despina Fotiou Ev Source Type: research

Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients
CONCLUSION: There was no association between HD DEX and mortality among ventilated COVID-19 patients compared to SD DEX. Moreover, HD DEX is associated with detrimental effects such as prolonged ICU LOS and higher average daily BG. This study supports the use of SD DEX in ventilated COVID-19 patients.PMID:37592771 | DOI:10.2174/1574886318666230817102043
Source: Current Drug Safety - August 18, 2023 Category: Drugs & Pharmacology Authors: Pramodini B Kale-Pradhan Regina Pacitto Christopher A Giuliano Leonard B Johnson Source Type: research